These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 23131151

  • 21. Methodology and effects of repeated intranasal delivery of DNSP-11 in a rat model of Parkinson's disease.
    Stenslik MJ, Potts LF, Sonne JW, Cass WA, Turchan-Cholewo J, Pomerleau F, Huettl P, Ai Y, Gash DM, Gerhardt GA, Bradley LH.
    J Neurosci Methods; 2015 Aug 15; 251():120-9. PubMed ID: 25999268
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Dopamine, Noradrenaline and Serotonin Receptor Densities in the Striatum of Hemiparkinsonian Rats following Botulinum Neurotoxin-A Injection.
    Mann T, Zilles K, Dikow H, Hellfritsch A, Cremer M, Piel M, Rösch F, Hawlitschka A, Schmitt O, Wree A.
    Neuroscience; 2018 Mar 15; 374():187-204. PubMed ID: 29421436
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Dopamine D₁ and D₂ receptor subtypes functional regulation in corpus striatum of unilateral rotenone lesioned Parkinson's rat model: effect of serotonin, dopamine and norepinephrine.
    Paul J, Nandhu MS, Kuruvilla KP, Paulose CS.
    Neurol Res; 2010 Nov 15; 32(9):918-24. PubMed ID: 20887679
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Modulation by desensitized nicotinic receptors on metabolism of DA in striatum derived from the hemiparkinsonian model].
    Fu-Rong H, Hai W.
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2016 Jun 08; 32(6):487-493. PubMed ID: 29926613
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine.
    Przedborski S, Levivier M, Jiang H, Ferreira M, Jackson-Lewis V, Donaldson D, Togasaki DM.
    Neuroscience; 1995 Aug 08; 67(3):631-47. PubMed ID: 7675192
    [Abstract] [Full Text] [Related]

  • 35. Neuroprotective effect of BDNF in young and aged 6-OHDA treated rat model of Parkinson disease.
    Singh S, Ahmad R, Mathur D, Sagar RK, Krishana B.
    Indian J Exp Biol; 2006 Sep 08; 44(9):699-704. PubMed ID: 16999024
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Methamphetamine induces fos expression in the striatum and the substantia nigra pars reticulata in a rat model of Parkinson's disease.
    Ishida Y, Todaka K, Kuwahara I, Ishizuka Y, Hashiguchi H, Nishimori T, Mitsuyama Y.
    Brain Res; 1998 Oct 26; 809(1):107-14. PubMed ID: 9795171
    [Abstract] [Full Text] [Related]

  • 39. Apomorphine priming alters the response of striatal outflow pathways to D2 agonist stimulation in 6-hydroxydopamine-lesioned rats.
    Pollack AE, Turgeon SM, Fink JS.
    Neuroscience; 1997 Jul 26; 79(1):79-93. PubMed ID: 9178866
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.